N-ras gene activation in the RD human rhabdomyosarcoma cell line - PubMed (original) (raw)
N-ras gene activation in the RD human rhabdomyosarcoma cell line
P Chardin et al. Int J Cancer. 1985.
Abstract
A transforming N-ras allele was molecularly cloned from the RD human rhabdomyosarcoma cell line, and the nature of its activation studied. Construction of chimeric recombinants between the RD-transforming allele and a normal human allele enabled us to localize the alteration responsible for the activation to the second exon of the N-ras gene. The nucleotide sequence of this exon, when compared to that of the normal allele, revealed a single difference at the 61st amino acid position of the encoded protein; the CAA codon for glutamine in the normal allele was mutated to a CAT codon for histidine in the RD-transforming allele. This result is the first description of a histidine replacing glutamine in the 61st position and provides further evidence that the 61st amino acid is one of the preferential sites for N-ras activation.
Similar articles
- Activation of an N-ras gene in acute myeloblastic leukemia through somatic mutation in the first exon.
Gambke C, Hall A, Moroni C. Gambke C, et al. Proc Natl Acad Sci U S A. 1985 Feb;82(3):879-82. doi: 10.1073/pnas.82.3.879. Proc Natl Acad Sci U S A. 1985. PMID: 3856237 Free PMC article. - Three different mutations in codon 61 of the human N-ras gene detected by synthetic oligonucleotide hybridization.
Bos JL, Verlaan-de Vries M, Jansen AM, Veeneman GH, van Boom JH, van der Eb AJ. Bos JL, et al. Nucleic Acids Res. 1984 Dec 11;12(23):9155-63. doi: 10.1093/nar/12.23.9155. Nucleic Acids Res. 1984. PMID: 6595642 Free PMC article. - Activation of a human c-K-ras oncogene.
Yamamoto F, Perucho M. Yamamoto F, et al. Nucleic Acids Res. 1984 Dec 11;12(23):8873-85. doi: 10.1093/nar/12.23.8873. Nucleic Acids Res. 1984. PMID: 6096811 Free PMC article. - Mechanism of activation of an N-ras oncogene of SW-1271 human lung carcinoma cells.
Yuasa Y, Gol RA, Chang A, Chiu IM, Reddy EP, Tronick SR, Aaronson SA. Yuasa Y, et al. Proc Natl Acad Sci U S A. 1984 Jun;81(12):3670-4. doi: 10.1073/pnas.81.12.3670. Proc Natl Acad Sci U S A. 1984. PMID: 6587382 Free PMC article. - Activation of N-ras in a human melanoma cell line.
Padua RA, Barrass NC, Currie GA. Padua RA, et al. Mol Cell Biol. 1985 Mar;5(3):582-5. doi: 10.1128/mcb.5.3.582-585.1985. Mol Cell Biol. 1985. PMID: 3887133 Free PMC article.
Cited by
- Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.
Marampon F, Ciccarelli C, Zani BM. Marampon F, et al. Mol Cancer. 2006 Aug 9;5:31. doi: 10.1186/1476-4598-5-31. Mol Cancer. 2006. PMID: 16899113 Free PMC article. - Caveolins in rhabdomyosarcoma.
Rossi S, Poliani PL, Missale C, Monti E, Fanzani A. Rossi S, et al. J Cell Mol Med. 2011 Dec;15(12):2553-68. doi: 10.1111/j.1582-4934.2011.01364.x. J Cell Mol Med. 2011. PMID: 21707915 Free PMC article. Review. - Oncogene mutation profiling of pediatric solid tumors reveals significant subsets of embryonal rhabdomyosarcoma and neuroblastoma with mutated genes in growth signaling pathways.
Shukla N, Ameur N, Yilmaz I, Nafa K, Lau CY, Marchetti A, Borsu L, Barr FG, Ladanyi M. Shukla N, et al. Clin Cancer Res. 2012 Feb 1;18(3):748-57. doi: 10.1158/1078-0432.CCR-11-2056. Epub 2011 Dec 5. Clin Cancer Res. 2012. PMID: 22142829 Free PMC article. - Deep Sequencing Reveals a Novel miR-22 Regulatory Network with Therapeutic Potential in Rhabdomyosarcoma.
Bersani F, Lingua MF, Morena D, Foglizzo V, Miretti S, Lanzetti L, Carrà G, Morotti A, Ala U, Provero P, Chiarle R, Singer S, Ladanyi M, Tuschl T, Ponzetto C, Taulli R. Bersani F, et al. Cancer Res. 2016 Oct 15;76(20):6095-6106. doi: 10.1158/0008-5472.CAN-16-0709. Epub 2016 Aug 28. Cancer Res. 2016. PMID: 27569217 Free PMC article. - Cell growth potential drives ferroptosis susceptibility in rhabdomyosarcoma and myoblast cell lines.
Codenotti S, Poli M, Asperti M, Zizioli D, Marampon F, Fanzani A. Codenotti S, et al. J Cancer Res Clin Oncol. 2018 Sep;144(9):1717-1730. doi: 10.1007/s00432-018-2699-0. Epub 2018 Jul 3. J Cancer Res Clin Oncol. 2018. PMID: 29971532
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous